PAGE2B

Across TCGA pan-cancer cohorts, PAGE2B Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated PAGE2B data layer compared with 22 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PAGE2B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PAGE2B expression acts as an unfavorable survival marker.

LUAD, LUSC, and SKCM are the cancer types where PAGE2B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.237	0.812	.001	15	view →
LUSC	OS	Median	All	0.138	0.776	<.001	12	view →
SKCM	DFS	Median	All	0.254	0.622	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PAGE2B–LUAD (OS)

Open the LUAD breakdown →